Edwards Lifesciences Corporation Cash and Restricted Cash
Edwards Lifesciences Corporation (EW) had Cash and Restricted Cash of $2.91 billion as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.91B.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.45B.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.94B.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.69B.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $2.91B 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $2.45B 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $2.94B 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $2.69B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $3.29B 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $3.15B 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $3.06B 10-Q · filed 2026-08-04 | |
| 2024-09-30 | $3.68B 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $1.66B 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $1.23B 10-Q · filed 2025-05-06 | |
| 2023-12-31 | $1.15B 10-K · filed 2026-02-25 | |
| 2023-09-30 | $1.41B 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $1.05B 10-Q · filed 2024-07-31 | |
| 2023-03-31 | $876.40M 10-Q · filed 2024-04-29 | |
| 2022-12-31 | $772.60M 10-K · filed 2026-02-25 | |
| 2022-09-30 | $1.25B 10-Q · filed 2023-10-27 | |
| 2022-06-30 | $1.20B 10-Q · filed 2023-07-28 | |
| 2022-03-31 | $1.04B 10-Q · filed 2023-04-28 | |
| 2021-12-31 | $867.40M 10-K · filed 2025-02-28 | |
| 2021-09-30 | $1.52B 10-Q · filed 2022-10-28 | |
| 2021-06-30 | $1.33B 10-Q · filed 2022-07-29 | |
| 2021-03-31 | $1.19B 10-Q · filed 2022-04-28 | |
| 2020-12-31 | $1.20B 10-K · filed 2024-02-12 | |
| 2020-09-30 | $1.03B 10-Q · filed 2021-10-29 | $1.02B 10-Q · filed 2020-10-26 |
| 2020-06-30 | $909.00M 10-Q · filed 2021-07-30 | $903.50M 10-Q · filed 2020-07-27 |
| 2020-03-31 | $668.30M 10-Q · filed 2021-04-28 | $662.90M 10-Q · filed 2020-04-28 |
| 2019-12-31 | $1.18B 10-K · filed 2023-02-13 | $1.18B 10-K · filed 2020-02-14 |
| 2019-09-30 | $1.19B 10-Q · filed 2020-10-26 | |
| 2019-06-30 | $726.80M 10-Q · filed 2020-07-27 | |
| 2019-03-31 | $709.20M 10-Q · filed 2020-04-28 | |
| 2018-12-31 | $715.90M 10-K · filed 2022-02-14 | $714.10M 10-Q · filed 2019-04-26 |
| 2018-09-30 | $1.26B 10-Q · filed 2019-10-25 | |
| 2018-06-30 | $1.23B 10-Q · filed 2019-07-26 | |
| 2018-03-31 | $1.23B 10-Q · filed 2019-04-26 | |
| 2017-12-31 | $820.20M 10-K · filed 2021-02-12 | $818.30M 10-Q · filed 2019-04-26 |
| 2016-12-31 | $930.10M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |